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It is generally believed that plasma membrane receptors for C3b and for the 
Fc  piece  of IgG  serve  very  different  functions  in  phagocytosis.  While  sheep 
erythrocytes (E) l bearing IgG (EA) are phagocytosed by human polymorphonu- 
clear leukocytes (PMN) and monocytes, E bearing C3b (EC3b) are bound to the 
plasma membrane  but are not ingested (1, 2). The addition of even very small 
amounts of IgG to EC3b leads to their efficient phagocytosis by both PMN and 
monocytes (3).  Thus,  particle-bound  IgG  is  generally  considered  a  signal  for 
phagocytosis, whereas particle-bound C3b has been thought  to mediate adher- 
ence to phagocytic cells but to be insufficient  to initiate  the phagocytic event. 
However, it has been shown that mouse peritoneal macrophages will ingest EC3b 
after exposure to lymphokines (4, 5). Thus,  iymphokine activation of the phag- 
ocytic cell, which presumably affects the nature of the interactions of the plasma 
membrane with the cytoskeleton (6), affects the ability of cellular C3 receptors 
to mediate phagocytosis. 
Recently, we have demonstrated  that  fibronectin (Fn),  a  440,000  D  plasma 
glycoprotein, is able to activate freshly isolated human  peripheral  blood mono- 
cytes  to  ingest  EC3b  (7).  In  these  experiments,  Fn-exposed  monocytes  also 
ingested more EA than  did unactivated monocytes; this increased phagocytosis 
did not require interaction of Fn with the erythrocyte and thus reflected a change 
in the phagocytic potential  of the monocyte itself. This work, as well as that of 
others (8-10),  suggests that  monocytes bear a  plasma  membrane  receptor  for 
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Fn.  In  the present study, we have explored the interaction of Fn with human 
leukocyte membranes by studying the binding of Fn-coated fluorescent particles 
to the cells, using flow cytometry. In addition, we have examined the binding of 
radiolabeled  Fn  to  monocytes  and  PMN  and  have  explored  the  functional 
consequences of interaction with Fn for phagocytosis. We have shown that PMN, 
like monocytes, bind Fn. In marked contrast to monocytes, however, phagocytosis 
by freshly isolated PMN is not affected by exposure to Fn. On the other hand, 
if the PMN are first activated by exposure to C5a or N-formyl-methionyi-leucyl- 
phenylalanine (fmet-leu-phe), then Fn has a marked effect on PMN phagocytosis. 
Most dramatically, these chemotaxin-activated neutrophils, which do not phag- 
ocytose EC3b in the absence of Fn, do, like monocytes, become actively phago- 
cytic for these same particles in its presence. 
Materials and Methods 
Buffers.  Isotonic Veronal-buffered saline (VBS), containing 0.1%  gelatin, 0.15  mM 
CaCI2,  1 mM MgCI2 (GVB÷+); low ionic strength isosmotic VBS with dextrose, gelatin, 
Ca  ++, and Mg  +÷ (DGVB), and VBS containing gelatin and 10 mM EDTA (EDTA-GVB), 
were prepared as described previously (11).  Phosphate-buffered saline (PBS) and RPMI 
1640 containing glutamine, penicillin, and streptomycin were obtained from the Media 
Unit, National Institutes of Health. 
Purification of Fn.  Human plasma Fn was purified by a modification (7) of the method 
of Vuento and Vaheri (12).  Briefly, the 5% polyethylene glycol 3350 precipitate from 
EDTA, benzamidine, and phenylmethylsuifonyl  fluoride (PMSF)-treated plasma was re- 
suspended in a buffer of 150 mM NaCI,  50 mM KH2POJK~HPO4, and 10 mM EDTA, 
pH 7.4. This plasma fraction was then absorbed by passage over Sepharose 4B (Pharmacia 
Fine Chemicals, Piscataway, N  J) and the Fn was purified by elution from gelatin-Sepharose 
with 1 M arginine. Further purification was obtained by adsorption to, and elution from, 
arginine-Sepharose. All buffers used for chromatography and elution contained 5 mM 
benzamidine, 1 mM PMSF, and/or 25 ~M para nitrophenyl para amidino benzoate to 
inhibit residual serine proteases. The purified Fn showed a single line on immunoelectro- 
phoresis vs. anti-whole human serum, and a single major band at 440,000 D on sodium 
dodecyl suifate-polyacrylamide gel electrophoresis (SDS-PAGE).  Upon the reduction of 
disulfide bonds,  SDS-PAGE  revealed a  closely  spaced doublet, as has  been  reported 
previously for human plasma Fn (13).  Antibodies raised against this Fn preparation in 
rabbits and goats gave a monospecific response on immunoelectrophoresis and Ouchter- 
Iony double diffusion against whole human plasma. 
Antibodies and Complement Components.  CI, C4, and C2 were purchased from Cordis 
Laboratories Inc., Miami, FL. Rabbit IgG and IgM anti-Forssman (14) and human C3 
were prepared as previously described (15). Human C5a was purified by immunoabsorp- 
tion of zymosan-activated, pooled, citrated plasma followed by ion exchange chromatog- 
raphy and gel filtration (L. Renfer, K. Yancey, C. Hammer, and M. Frank, manuscript in 
preparation). In brief, 1 M epsiion-aminocaproic acid, 10 mM MgCI~, and citrated plasma 
were incubated with boiled zymosan. The supernatant of an acid precipitation of the 
mixture was adjusted to pH 5.0 with 10 N NaOH, exposed to a solid-phase  immunoad- 
sorbent bearing antibody directed against C5a. C5a was eluted from the immunoadsorbent 
and then chromatographed sequentially on CM 52 ion exchange resin (Whatman Ltd., 
Maidstone, Kent, England) and Sephadex G-75  (Pharmacia Fine Chemicals).  C5a was 
identified in column fractions by Lowry protein determinations, bioassay, and immunoblot 
techniques using specific antibody staining. The C5a prepared in this manner migrated 
as a  15,000  D band on SDS-PAGE.  When this band was transferred to nitrocellulose 
sheets after electrophoresis (16), reactivity with specific anti-C5 antibody was confirmed. 
Fmet-leu-phe was purchased from Sigma Chemical Co., St. Louis, MO. 
Production ofMonoclonal  Anti-Fn Antibodies.  Monoclonal anti-Fn antibodies were pro- POMMIER  ET  AL.  139 
duced by the method of K6hler and Milstein (20).  Briefly, BALB/c mice were injected 
with  100 tzg of purified Fn subcutaneously in complete Freund's adjuvant. 2-4 wk after 
initial  immunization,  selected mice were injected  intravenously with  50 ~tg of Fn.  3  d 
later, the spleens were removed and individual spleen cells were fused with the SP2/0 
nonsecretor myeloma cell line. Anti-Fn antibody production by fusions was detected using 
an  enzyme-linked  immunosorbent  assay  in  which  purified  Fn  was  adsorbed  to  flat- 
bottomed microtiter wells  (Immuion I; Dynatech  Laboratories, Inc., Alexandria,  VA). 
Cell  culture  supernatants  were  added  in  a  dilution  of  1:10  in  PBS  containing  0.05% 
Tween 20 (Mallinkrodt  Chemical Co., St.  Louis,  MO) and incubated for 2  h  at 37°C. 
Then, antibody binding was detected using horseradish peroxidase-conjugated goat anti- 
mouse immunoglobulin (Cappel Laboratories, Cochranville, PA). Monoclonai antibodies 
were used in experiments as unfractionated culture supernatants. All the anti-Fn mono- 
clonals used were IgG1 antibodies. 
Leukocyte Purification.  Whole human  blood was collected from normal volunteers in 
full units drawn with citrate phosphate dextrose anticoagulant by the Washington  D.C. 
Regional  Blood Services.  Platelet-rich plasma was removed within  3  h  of collection by 
centrifugation at 2,600 g for 3.5  rain. The huffy coat (40 ml of the top layer of packed 
cells)  was collected and  then  used  immediately for isolation  of leukocytes.  Peripheral 
blood mononuclear cells were separated from the buffy coat on Ficoll-Hypaque gradients. 
Monocytes were isolated using a J2-21 centrifuge (Beckman Instruments, Inc., Paio Alto, 
CA)  equipped  with  a JE-6  elutriator  rotor  with  two  Sanderson  separation  chambers, 
following a procedure modified from Lionetti et al. (17).  The purity of the monocytes 
was ~95% as determined by both morphology and nonspecific esterase staining (Tech- 
nicon Instruments Corp., Tarrytown, NY). Peripheral blood lymphocytes were similarly 
isolated from the FicolI-Hypaque gradients by pooling non-monocyte-containing fractions 
from  the  elutriation  of mononuclear  cells.  Less  than  5%  of these  cells  stained  with 
nonspecific esterase or exhibited phagocytosis of optimally sensitized EA.  Alternatively, 
in some experiments, lymphocytes and monocytes were separated on preformed gradients 
of polyvinylpyrrolidone-modified colloidal silica  (Percoll; Pharmacia Fine Chemicals) as 
described (18). Monocytes isolated in this manner were indistinguishable from elutriated 
monocytes with respect to the percentages that bound Fn-coated fluorescent microspheres 
(ms),  the  number  of ms bound  per cell,  and  the  ability  to phagocytose EC3b  in  the 
presence of Fn.  Neutrophils  were isolated from the  Ficolt-Hypaque pellets by dextran 
sedimentation (19) without hypotonic lysis since there was no visable erythrocyte contam- 
ination. 
Opsonized Sheep E.  E were collected, washed, and stored using standard methods (13). 
For the preparation of C3b-opsonized particles, E were sensitized with IgM anti-Forssman 
antibody. C 1, C4, C2, and C3 were then added sequentially as previously described (10). 
The concentration of C4 was limited to prevent interaction of EAC 14 with C3b receptors. 
For experiments with monocytes, EAC142 were incubated with 5 U of C3 to yield 100- 
200 C3b molecules per cell. After sensitization with C3, EAC1423b were incubated for 1 
h  in  EDTA-GVB to remove C1  and  to allow C2  to decay, and  then  washed twice in 
GVB  ÷+ (EC3b).  For the preparation of EA,  1 X 109 E/ml were incubated for 30 min at 
37°C with a  1:2,000 dilution of IgG anti-Forssman antibody. The cells were then washed 
twice in GVB  +÷ and resuspended in DGVB. Preliminary experiments revealed that PMN 
rosetted with  EA and EC3b less well than with monocytes. Therefore, for use in PMN 
experiments, the IgG anti-Forssman was diluted only 1:250-1:500 during preparation of 
EA, and EC3b were prepared that bore 10,000 C3b per cell. 
Rosetting and Phagocytosis Assay.  For the assay of leukocytes in suspension, 50 #1 of cells 
at 2 x  106/ml in RPMI 1640 supplemented with 5 mM MgCI~ were incubated for 30 min 
in a 5% COJ95% air incubator at 37°C with Fn or, as a control, Fn passed over gelatin- 
Sepharose immediately before the experiment. In all experiments, this gelatin-Sepharose- 
passed Fn was used as the "no Fn added" control. Without exception, getatin-Sepharose- 
passed  Fn  and  buffer  have  given  identical  results  in  assays  of monocyte  and  PMN 
phagocytosis of EA and of EC3b.  In some experiments, leukocytes were incubated with 
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in RPMI 1640 before incubation with Fn. Except where noted, after incubation with Fn, 
the leukocytes were mixed with 50 #1 of EC3b or EA at 1.5 X 108 E/ml without washing. 
The cells and indicator particles were sedimented by centrifugation for 5  min at  50 g, 
incubated for a further 30 min in a 5% CO~/95% air incubator at 37°C without mixing, 
and  then  gently  resuspended  and  examined  under  light  microscopy.  To  quantitate 
phagocytosis, extracellular  E were lysed by mixing the cells with a buffer of 1 part PBS 
and  4  parts  HeO  for a  few  seconds.  In all  experiments,  at  least  200  leukocytes were 
counted to quantitate  E rosetting or ingestion.  Three or more E bound to a  leukocyte 
was considered a rosette. Total intracellular E were counted as a function of the number 
of white blood cells observed. 
Binding of Protein-coated Microspheres to Leukocytes.  Fluorescent microspheres (ms) (Cov- 
aspheres-MX; Covalent Technology Corp., Ann Arbor, MI), with an average diameter of 
1.0  ~m,  were  covalently  bound  to  Fn  (Fn-ms),  gelatin  (gelatin-ms),  or  bovine  serum 
albumin  (BSA-ms),  according  to  manufacturer's  instructions.  Briefly,  10  #1  of an  ms 
suspension were mixed with  10 #g of protein in  100 #! of PBS, sonicated, and incubated 
at room temperature for 1 h. The coated spheres were then washed twice in RPMI 1640 
plus  1% BSA, resuspended to 0.5 ml, and resonicated.  Each preparation was checked by 
microscopy to assure a suspension of unaggregated particles. In some experiments, gelatin- 
ms were incubated  with Fn at a  final concentration of 200  ug/ml  for 30  rain at room 
temperature.  The beads were then washed and sonicated once more before incubation 
with monocytes. To evaluate  cell binding,  the ms were mixed with an equal volume of 
monocytes or PMN at  1 ×  106 cells/ml, centrifuged at 50 g for 5 min, and incubated for 
30  min  at  37°C  in  a  buffer containing 0.05%  azide  to inhibit  endocytosis of the  ms. 
Finally, leukocytes were separated from free beads by centrifugation through 1 ml of 6% 
BSA in RPMI  1640 for  1 min at  12,000 g. The cell pellet was resuspended and a drop 
was placed on a  microscope slide.  Initially, the cells were examined by fluorescence and 
phase microscopy. Cells binding at least  3 ms were considered positive, and the percent 
of leukocytes positive for ms bearing each protein were determined by counting 100-200 
cells. Subsequently, the cells were examined by flow cytometry to analyze ms binding in 
greater detail, and the total number of ms bound to each cell was determined from the 
cell-associated fluorescence. 
To study the inhibition of Fn-ms binding to cells by fluid phase Fn or by monoclonal 
antibodies,  ms were incubated initially with only 1 ~g of Fn. After washing, Fn-ms were 
then incubated with 10 #g/ml of BSA to block unreacted sites on the ms. To examine the 
inhibition of Fn-ms binding by fluid phase Fn, monocytes and PMN were first incubated 
for 30 rain at 37 °C with varying concentrations of Fn in RPMI 1640/azide and then with 
Fn-ms exactly as described above. To examine the effect of monoclonal anti-Fn antibodies, 
50  #1 of Fn-ms were  incubated  for 30  min at  37°C with  75  #1 of culture  supernatant 
containing a  monoclonal anti-Fn and then incubated as described above with 2.25 x  105 
leukocytes in a  total volume of 200 ~1 for 30 min at  37°C. After the separation  of the 
free from the cell-bound Fn-ms, the cells were analyzed for ms binding by flow cytometry. 
In some experiments, monocytes were preincubated with a human IgG1 myeloma known 
to interact with the monocyte Fc receptor, and the PMN were incubated with monocional 
antibody  3G8  (New  England  Nuclear,  Boston,  MA),  which  recognizes  the  PMN  Fc 
receptor. After 30 rain,  Fn-ms were added without washing. Although these preincuba- 
tions totally inhibited EA rosetting with monocytes and PMN they did not influence the 
effect of monoclonal antibodies on Fn-ms binding. 
Binding of~SLFn to Monocytes and PMN.  Fn was radiolabeled with '2sI by the iodobead 
method according to manufacturer's instructions (Pierce Chemical Co.,  Rockford, IL). 
Final specific activity of the radiolabeled Fn ranged from 3 to 5 ×  10  s cpm/#g. Immediately 
prior to binding experiments, ~251-Fn was centrifuged for 10 min at 12,000 g in a microfuge 
(Beckman  Instruments,  Inc.,  Irvine,  CA)  or  for  10  min  at  180,000  g  in  an  airfuge 
(Beckman  Instruments,  Inc.) to remove aggregates.  Preliminary experiments  indicated 
that  the  specific uptake  of radiolabeled  Fn  was not  significantly different  for the  two 
preparations, or in comparison to uncentrifuged ~25I-Fn. Aliquots of radiolabeled Fn were 
incubated in duplicate with 2 ×  106 purified monocytes or 4  ×  l0 s PMN in RPMI 1640 POMMIER  ET  AL.  141 
containing 1% BSA and 0.05% azide in a total volume of 0.5 ml. Nonspecific binding was 
assessed  by including a  100-fold excess of unlabeled Fn in the incubation mixture. Free 
and  cell-bound  radiolabe[  were  separated  by  centrifugation of the  mixture  through 
Versilube  F-50  (General  Electric  Co.,  Waterford,  NY).  Unbound  and  cell-associated 
radioactivity were determined by counting aliquots of the aqueous supernatant and the 
entire cell pellet, respectively. Initial kinetic experiments indicated that binding equilib- 
rium was reached after a 1-h incubation. Therefore, saturation binding experiments were 
performed by incubating  ~25I-Fn with leukocytes as described above at  37°C  for  1 h. 
Nonspecific binding represented 1.0%  of input at all concentrations of the ~SI-Fn used 
for both monocytes and PMN. Total binding was 6-7 times higher than background for 
monocytes and  for PMN at  the  lowest inputs of Fn.  When  cells  bearing ~2~I-Fn were 
washed and reincubated in buffer at 370C, >70% of the specifically bound radiolabel was 
released. 
Expression of Data.  Statistical analyses were performed using Student's t test on popu- 
lation means. Except where indicated, data are expressed as mean +  standard deviation. 
Figures show representative experiments except as indicated. 
Results 
Effect of Fn  on EC3b and EA Phagocytosis.  As  previously reported (7),  fluid- 
phase  Fn induced phagocytosis of EC3b by monocytes. However, exposure of 
PMN  to  fluid-phase  Fn  did  not  lead  to  EC3b  phagocytosis  (Fig.  1).  Fn  also 
increased  monocyte phagocytosis  of EA  in  a  dose-dependent  fashion  and  in- 
creased monocyte rosettes with both EC3b and EA as described (7, 8). In striking 
contrast, Fn affected none of these functions of neutrophils. 
Binding of Fn-ms to Peripheral  Blood Leukocytes.  To investigate the difference 
between monocytes and PMN in their phagocytic response to Fn, we first tested 
the  hypothesis that  neutrophils  did  not  possess a  membrane  receptor for Fn. 
Therefore, we examined the binding of Fn-ms to freshly isolated human periph- 
eral blood leukocytes. In  initial  experiments,  monocytes and  PMN  were incu- 
bated with increasing numbers of Fn-ms,  gelatin-ms,  or BSA-ms for 30 min at 
37°C.  At  all  inputs  of ms,  <1%  of the  cells  bound  gelatin-ms  or  BSA-ms  as 
assessed  by  fluorescence  microscopy.  In  contrast,  the  majority  of monocytes 
bound  Fn-ms.  These  visual  data  were confirmed by flow cytometry. Whereas 
very little cell fluorescence was found when cells were incubated with gelatin-ms 
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FIGURE  1.  The effect  of Fn on pbagocytosis  by PMN and monocytes. The ingestion of EC3b 
by PMN and monocytes is plotted as a function of fluid-phase Fn concentration for monolayer 
monocytes (O), fluid-phase monocytes (O), and PMN (A). None of the cells ingested EC3b in 
the absence of Fn. Whereas monocytes responded to Fn with EC3b phagocytosis, PMN did 
not. Data are represented as the mean +_ standard deviation of five separate experiments. 142  FIBRONECTIN RECEPTORS  OF  HUMAN  LEUKOCYTES 
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Binding of gelatin-ms and Fn-ms by peripheral  blood leukocytes. In A, a repre- 
sentative  flow  cytometric analysis  of ms  binding  to  monocytes is  shown.  B  illustrates  a 
representative  analysis of binding by PMN. In both panels, the dashed line illustrates binding 
of gelatin-ms and the solid line shows the binding of gelatin-ms that were first incubated  with 
200 ttg/ml of Fn. In both panels, binding of Fn-ms greatly exceeds binding of gelatin-ms. The 
average number of Fn-ms bound per monocyte exceeded the average number bound to 
individual PMN, although somewhat more PMN than monocytes bound Fn-ms. 
or BSA-ms (<2% of cells bound more than one ms), a broad peak of fluorescence 
was obtained when monocytes were incubated with Fn-ms (Fig. 2A). As the ratio 
of ms to  monocytes was  increased,  the  percentage  of monocytes binding  to at 
least  three  Fn-ms  reached  a  plateau  at  ~60%  (Fig.  3).  Examination  of  the 
monocytes of 18 different unrelated  healthy blood donors with an optimal ratio 
of Fn-ms to monocytes revealed that 58 +  5% SD of elutriator-purified monocytes 
specifically  bound  Fn-ms.  When  gelatin-ms  were  allowed  to  bind  Fn  before 
incubation with monocytes, binding of the ms also occurred (48 _+ 7% monocytes 
positive, n =  4). This demonstrated that Fn-ms would bind to monocytes whether 
the Fn was incubated directly with ms or was allowed to bind to gelatin that had t00 
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FIGURE 3.  Dose response of Fn-ms binding to PMN and monocytes. The dose response of 
the addition of increasing numbers of Fn-ms (O, A) and gelatin-ms (0, A) to monocytes ((3, O) 
and PMN  (A, &) is plotted as the percent of cells binding ms vs. the number of ms added. 
Gelatin-ms did not bind significantly to PMN or monocytes. Fn-ms binding to both cell types 
reached a plateau at similar inputs of ms. Since not all PMN or monocytes could bind Fn-ms, 
these data imply that there are subpopulations of PMN and monocytes which bind Fn. 
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FIGURE 4.  Binding of Fn-ms by PMN, monocytes, and lymphocytes. The number of cells 
binding Fn-ms was determined for  PMN,  monocytes, and lymphocytes of 15-18  different 
normal individuals. The data are represented as mean percent of cells binding +  SD. 
been linked to the ms. Moreover, the elutriation technique for purifying mono- 
cytes  was  not  selecting  a  subset  of cells,  since  purification  of monocytes  on 
preformed  Percoil  gradients  rather  than  by  elutriation  did  not  change  the 
percentage of cells binding Fn-ms. 
Although  Fn  had  no effect on  phagocytosis by freshly purified  PMN,  these 
ceils also specifically bound Fn-ms (Fig. 2B). Like monocytes, PMN did not bind 
significant numbers of gelatin-ms or BSA-ms, and incubation of gelatin-ms with 
Fn led to ms binding similar to that when Fn-ms were incubated with PMN. The 
plateau for Fn-ms binding to PMN occurred at a bead/leukocyte ratio similar to 
that for monocytes (Fig. 3). In fact, a higher percentage of PMN (70 _  8%, n = 
15) than  monocytes bound Fn-ms (P <  0.001) (Fig.  4).  This was true when the 
monocytes and  PMN  of individual  donors  were  compared,  as  well as  for  the 
population means.  However, monocytes bound more Fn-ms per cell than PMN. 
The  mean  fluorescent  channel  for  monocytes binding  Fn-ms  was  300,  corre- 144  FIBRONECTIN  RECEPTORS  OF  HUMAN  LEUKOCYTES 
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FIGURE 5.  Inhibition of Fn-ms binding by fluid-phase Fn. PMN (0) and monocytes (&) were 
incubated with increasing concentrations of Fn and then assessed for binding of Fn-ms as 
described in Materials and Methods.  Fluid-phase Fn inhibited the binding of Fn-ms to both 
cell types in a dose-related fashion. 
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FIGURE 6.  Temperature dependence of Fn-ms binding. The ability of monocytes and PMN 
to bind Fn-ms was evaluated at 4°C and 37°C. Both cell types showed increased binding of Fn 
at elevated temperatures. 
sponding to ~55 ms per cell; for PMN, it was 35, corresponding to seven ms per 
cell. Lymphocytes did not bind more Fn-ms than gelatin-ms or BSA-ms (Fig. 4). 
To  confirm  the  specificity of binding  of Fn-ms,  PMN and  monocytes were 
incubated with fluid-phase Fn before mixing with Fn-ms bearing  1/10 the usual 
amount of Fn. A dose-dependent inhibition of Fn-ms binding by fluid-phase Fn 
was demonstrated for both PMN and monocytes (Fig. 5). 
Effect  of Temperature  and  Protease  Inhibitors  on  Fn-ms  Binding  to  PMN  and 
Monocytes.  Fn-ms bound to both PMN and monocytes, yet, only monocytes were 
stimulated  by Fn  to induce  phagocytosis of EC3b.  Hence,  we considered  the 
possibility that the plasma membrane molecules that bound Fn differed for the 
two  cell  types.  To  investigate  this  possibility,  several  experiments  were  per- 
formed. As previously detailed, the binding of Fn-ms to both PMN and mono- 
cytes was inhibited by fluid-phase Fn, demonstrating that the membrane receptor 
on  both  cells  recognize  the  Fn  molecule  in  solution.  We  next  compared  the 
temperature dependence of the binding of Fn-ms to the two cell types. For both 
PMN and monocytes, Fn-ms binding was greatly decreased but not abolished at 
4°C (Fig.  6).  Because PMN enzymes can cleave Fn (21, 22), the possibility that 
cleavage of Fn was required for Fn-ms binding to PMN was considered. However, 
PMN and monocytes both bound equal numbers of Fn-ms in the presence and 
absence of 2 mM PMSF, an inhibitor known to prevent cleavage of Fn by PMN POMMIER  ET  AL.  145 
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FIGURE 7.  Effect of C5a and fmet-leu-phe on the ability of Fn to induce EC3b phagocytosis 
by PMN. The ingestion of EC3b by PMN exposed to C5a (O), fmet-leu-pbe (O), or buffer (&) 
is plotted as a function of Fn concentration. In the absence of Fn, CSa- and fmet-leu-phe- 
stimulated PMN did not phagocytose EC3b. In the absence of C5a or fmet-leu-phe exposure, 
Fn did not induce phagocytosis of EC3b. When PMN were first exposed to either chemotactic 
agent, they showed an Fn dose-related ingestion of EC3b. 
TABLE  I 
Inhibition of Fn-ms Binding by Monoclonal Anti-Fn IgG * 
Monoclonal 
Antibodies 
Percent inhibition* 
Monocytes (n =  5)  !  PMN (n =  3)  I 
None  0  0 
3G4-2  57.6 +  2.71  80.1  ±  1.1 
3Cll  53.0 + 3.4  82.1 ± 2.7 
5C9  8.6 ± 2.1  17.9 ± 9.8 
6D4  16.9 ±  7.6  11.7 ±  13.9 
* Fn-ms were prepared with  1 ug of Fn, as described in Materials and 
Methods, before incubation with monoclonal antibodies. 
* Percent inhibition --  100  x  [1  -  (cells binding Fn-ms incubated with 
monoclonal antibodies)/(cells binding Fn-ms in absence of monoclonal 
antibodies)]. 
| n,  number of different occasions  on which each experiment was per- 
formed, singly or in duplicate. 
! Mean percent inhibition + SEM. 
proteases (22). 
Effect  of Monoclonal  Anti-Fn  Antibodies  on  the  Binding  of Fn-ms  to  PMN  and 
Monocytes.  We next used monoclonal anti-Fn antibodies to examine whether the 
PMN  and  monocyte  Fn  receptors recognized similar sites on  the  Fn  molecule. 
Two  monoclonal antibodies that inhibited Fn-ms binding to monocytes and two 
that did not  were  tested for their ability to inhibit ms binding to  PMN.  There 
was a  complete correspondence  between the inhibition of binding by the mono- 
clonals on PMN  and on monocytes, implying that the membrane  Fn binding site 
on the cells recognized similar domains on the Fn molecule (Table I). 
Effect  of C5a  and fmet-leu-phe  on  Fn-induced  EC3b  Phagocytosis  by PMN.  The 
data comparing Fn-ms binding to PMN and monocytes suggested that the surface 
molecules that recognized  Fn on the two types of phagocytic cells were similar. 
To determine ifPMN  could be induced to respond to Fn by increasing phagocytic 
activity, neutrophils were incubated with C5a or fmet-leu-phe for 10 min at 37 °C 146  FIBRONECTIN  RECEPTORS  OF  HUMAN  LEUKOCYTES 
before exposure to Fn.  PMN  thus treated bound more EA and  EC3b than did 
unactivated cells, as has been previously reported (23). However, PMN incubated 
with C5a or fmet-leu-phe remained unable to ingest EC3b in the absence of Fn. 
In marked contrast,  when these activated neutrophils were incubated with  Fn, 
they  ingested  EC3b  efficiently and  in  a  Fn  dose-dependent  manner  (Fig.  7). 
Similar data were obtained with EA:  although buffer-incubated cells did ingest 
some EA in the absence of Fn,  Fn did not increase phagocytosis by these cells. 
In contrast, Fn increased EA ingestion by PMN  incubated with C5a and fmet- 
leu-phe from 47  to  94  E  per  100  PMN  and  from 42  to  82  E  per  100  PMN, 
respectively. The dose-response curves for both the C5a and  the fmet-leu-phe 
requirement for PMN  phagocytosis of EC3b showed that increased concentra- 
tions of the chemotaxins led to increased effect (Fig. 8), as has been demonstrated 
for neutrophii  granule  secretion, without  the high dose  unresponsiveness  that 
has been demonstrated in assays of PMN chemotaxis (24). Exposure of PMN to 
fmet-leu-phe or  C5a  was  required  before exposure to  Fn  to achieve efficient 
Z  60 
8 
h 
10  -10  10  "~  10"6 
Imlp IM/L)  / 
1O-lz  10-~o  lO-J 
CSa (M/L} 
FIGURE 8.  Dose  response of fmet-leu-phe (fmlp) and  C5a effect on PMN. The effect of 
preincubation with fmet-leu-phe on subsequent EC3b ingestion by PMN incubated with 80 
pg/ml of Fn is shown in the left panel. A similar dose-response curve for Cba is shown in the 
right panel. 
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FIGURE 9.  Binding  of l~5I-Fn by monocytes and PMN. The binding of l~SI-Fn by monocytes 
(0) and by PMN incubated with buffer (O), 10  -s M fmet-leu-phe (A), or 10  -s M C5a (r-I) is 
plotted as a function of ~5I-Fn input. Monocytes bound more 125I-Fn than PMN. C5a and 
fmet-leu-phe incubation did not change the amount of ~51-Fn binding by PMN. POMMIER  ET  AL.  147 
phagocytosis  of EC3b.  When  the  order  of exposure  was  reversed and  the 
neutrophils were first exposed to 160 t~g/ml Fn, a maximum of only nine EC3b 
per 100  PMN were ingested by cells subsequently incubated with fmet-leu-phe 
and only 16 EC3b per 100 PMN were ingested by cells subsequently incubated 
with C5a. 
Since PMN bound fewer Fn-ms than monocytes, we tested whether C5a and 
fmet-leu-phe acted on PMN to increase the number of neutrophil Fn receptors. 
Using Fn-ms suboptimally coated with Fn, neither the number of cells binding 
Fn-ms nor the number of ms bound per cell changed after C5a or fmet-leu-phe 
treatment. This lack of effect of the PMN activators on Fn receptor number was 
confirmed by studies of the uptake of radiolabeled Fn, which showed that the 
curves for ~eSI-Fn binding to buffer, C5a-, and fmet-leu-phe-treated PMN were 
similar (Fig. 9). At each input of radiolabel, less Fn was bound by either activated 
or buffer-treated PMN  than  by monocytes. This finding is in agreement with 
the differences noted between the two cell types in the binding of Fn-ms. 
Discussion 
In this study we have investigated both the morphological characteristics and 
the functional consequences of the binding of Fn by human peripheral blood 
phagocytic cells. We have been able to study the interaction of Fn with PMN 
and monocytes in two independent ways. One approach involved direct study of 
the binding of either Fn-ms or 125I-Fn to the cells. The other required that Fn 
affect the cell membrane in a way to cause the phagocytic cell to recognize C3b 
bound  to  E,  normally only a  signal  for  leukocyte adherence, as  a  signal  for 
phagocytosis. This latter functional assay apparently required Fn effects on the 
cell beyond simple membrane binding since freshly isolated PMN bound both 
Fn-ms and fluid-phase Fn, but were not stimulated by Fn to ingest EC3b. The 
disparity between human peripheral blood monocytes and PMN  in  this latter 
phagocytic assay was the starting point for the investigations reported here. 
There is evidence from a number of systems that monocytes and macrophages 
bind Fn at the plasma membrane (7-10).  It has been suggested (25) that fluid- 
phase Fn will not bind to cells and that a conformational change in Fn, induced 
by binding to other molecules, is required for cell binding. However, our data 
clearly demonstrate that fluid-phase Fn will bind to monocytes. Free Fn inhibited 
the binding  of Fn-ms to  monocytes, l~SI-Fn in,solution  bound specifically to 
monocytes, and Fn coupled directly to ms bound to monocytes, as efficiently as 
Fn that adhered to gelatin-ms. Since Fn that was aggregated on a  fluorescent 
microsphere or a  gelatin-coated latex bead would have higher avidity for the 
receptor than  monomeric Fn,  the  major  effect of ligand  binding  by  Fn  for 
subsequent cell binding may be to aggregate Fn molecules rather than to expose 
a  cryptic  cell-binding  domain  by  inducing  a  conformational  change  in  the 
molecule. This hypothesis is supported by the identification and isolation of a 
cell (fibroblast)-binding fragment of Fn that is exposed in the native molecule 
and that retains its ability to bind to cells when cleaved from all other domains 
of the molecule necessary for ligand binding (26). 
The existence of a plasma membrane receptor for Fn on PMN has been less 
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of Fn-coated particles to PMN (27, 28), in other systems, binding of PMN to Fn 
has not been observed (8).  No investigators have been able to demonstrate that 
PMN will ingest particles opsonized solely by Fn.  In this study, we have demon- 
strated that PMN indeed can bind Fn at the cell membrane.  However, binding 
is quantitatively  less than  for monocytes, as judged by both  Fn-ms and  125I-Fn 
binding. This may explain the discrepancies among other investigations since, in 
systems that  require high avidity interaction,  PMN binding to Fn might not be 
observed. As with monocytes, PMN binding of Fn-ms was inhibitable by sufficient 
concentrations of fluid-phase Fn, and PMN bound 125I-Fn directly, implying that 
a ligand-induced conformational change in the Fn molecule was not required for 
cell binding. 
The heterogeneity among peripheral blood PMN and monocytes with respect 
to Fn-ms binding suggests that this property may mark a subset of each of these 
cell types. Although it is possible that cells bearing Fn receptors were lost during 
the assay of phagocytes in the fluid phase, it is interesting that the percentage of 
monocytes that bound Fn-ms was equal to the percentage that were stimulated 
by Fn  to ingest opsonized E  (cf., Fig.  2  in reference  7).  Since this  was true  of 
monocytes that were allowed to adhere to glass before assay, as well as of fluid- 
phase cells, it is likely that Fn-ms binding marks a monocyte subpopulation that 
will be stimulated by Fn to phagocytose. Because of the low number of E ingested 
by PMN,  it was impossible to be certain  that  Fn-ms binding correlated with  E 
ingestion  for  these  cells.  However,  the  percentage  of PMN  engaged  in  Fn- 
induced phagocytosis never exceeded the number that bound Fn-ms. 
A  striking  finding  in  this  study  is  that,  as  isolated  from  the  blood,  only 
monocytes are induced by Fn to ingest EC3b, although both PMN and monocytes 
possess membrane receptors for the Fn molecule. Since Fn is known to be able 
to bind to a wide variety of ligands through different domains of the molecule, 
we tested whether the difference in functional consequences of Fn binding could 
be explained  by differences in  the portion  of the molecule recognized  by the 
cells. However, several lines of investigation suggested that the Fn receptors on 
PMN and monocytes were quite similar and recognized very similar domains on 
Fn. Binding of Fn-ms to both cell types was inhibited by fluid-phase Fn at similar 
concentrations, implying that there was no major difference in the affinity of the 
Fn-receptor interaction between PMN and monocytes. The two cell types showed 
similar decreases in binding Fn-ms at 0°C, and neither required Fn cleavage by 
cellular proteases before binding the Fn-ms. Most importantly, monoclonal anti- 
Fn  antibodies  had  similar  effects on  Fn-ms  binding  by monocytes and  PMN. 
Anti-Fn  monoclonais  that  did  not  block binding  to  monocytes did  not  block 
binding  to  PMN;  similarly,  monoclonals  that  blocked  ms  binding  to  one  cell 
blocked binding to the other as well. Thus, it was unlikely that the difference in 
the functional effect of Fn binding to PMN and monocytes could be explained 
by the presence of different membrane receptor molecules on the two cell types. 
The  apparent  similarities  between  the  PMN  and  the  monocyte  membrane 
receptors for Fn  led to an  investigation of whether PMN could be induced  to 
demonstrate  a  functional  change  upon  exposure  to  Fn.  We  tested  whether 
activation  of  PMN  by  a  separate  signal  is  required  for  Fn  to  induce  PMN 
ingestion of EC3b. Indeed, exposure of PMN to C5a and fmet-leu-phe did cause POMMIER  ET  AL.  149 
PMN  to  phagocytose  EC3b  upon  subsequent  incubation  with  Fn.  Thus  two 
stimuli were required for ingestion of EC3b by PMN. This contrasts strikingly 
with monocyte ingestion of EC3b,  for which Fn alone was sufficient to induce 
phagocytosis.  The  two  signals  to  the PMN  did not  hav  e  independent effects 
since, if the order in which they were incubated with PMN  was reversed, no 
EC3b phagocytosis was induced. Exposure to C5a or fmet-leu-phe was required 
to  make  PMN  responsive  to  Fn.  Since  PMN  have  fewer  Fn  receptors  than 
monocytes, it was possible that C5a and fmet-leu-phe caused PMN to become 
responsive to Fn by increasing the number of Fn receptors. However, chemotaxin 
exposure did not induce a change in Fn receptor number, as judged by both Fn- 
ms and  l~I-Fn  binding.  Therefore, freshly isolated  PMN  possess a  sufficient 
quantity of Fn  receptors to  mediate the  Fn  effect on  phagocytosis of EC3b. 
Rather,  C5a  and  fmet-leu-phe must  affect the  nature of the  transmembrane 
signal generated by the occupancy of the Fn receptor. 
The mechanisms by which these changes occur in the phagocytic state of PMN 
and  monocytes are  unknown.  The  number  of monocyte IgG  Fc  membrane 
receptors  is  not  influenced  by  Fn  (7),  even  though  the  ingestion  of EA  is 
dramatically increased. The number of PMN  Fn  receptors is  not changed by 
C5a or fmet-leu-phe, even though the cell passes from a  Fn-unresponsive to a 
Fn-responsive state.  Thus,  the effects on phagocytosis demonstrated here are 
unlikely to reflect changes in the number of expressed receptors and more likely 
arise  from changes in  the interaction  of the receptors with  other membrane 
proteins and the cell cytoskeleton. It is possible that, after C5a or fmet-leu-phe 
exposure, the mobility of the Fn receptors in  the membrane is changed (29), 
that new associations with cytoskeletal elements are induced (30), or that a new 
physical association of the Fn receptor with the C3b receptor occurs (31).  The 
potential  physiologic  importance of this  requirement for  activation  of PMN 
before  Fn-induced phagocytosis of EC3b  will  occur is  clear.  The  phagocytic 
process is accompanied by the release of proteolytic enzymes and mediators of 
inflammation potentially harmful to the host. The requirement for activation by 
chemotactic factors  before the  full  phagocytic potential  of PMN  is  achieved 
would effectively limit phagocytosis by granulocytes to  the inflammatory foci 
into which they have migrated. 
Summary 
We have investigated the interactions between plasma fibronectin (Fn) and 
human peripheral blood phagocytic cells.  As shown by studies of the binding of 
Fn-coated fluorescent microspheres (Fn-ms), both polymorphonuclear leukocytes 
(PMN) and monocytes had specific binding sites for Fn at the plasma membrane. 
However, as  purified  from blood,  only monocytes were stimulated by Fn  to 
become more actively phagocytic. This increase in phagocytosis was reflected by 
an Fn-induced increase in  the ingestion of IgG-coated erythrocytes and, more 
dramatically by an Fn-dependent initiation of phagocytosis of C3b-coated eryth- 
rocytes. Despite this difference between PMN and monocytes in the functional 
consequences of Fn binding, the cell surface molecules responsible for Fn binding 
on the two cell types shared many characteristics. On both cells, binding of Fn- 
ms was inhibited by sufficient concentrations of fluid-phase Fn; both PMN and 150  FIBRONECTIN  RECEPTORS  OF  HUMAN  LEUKOCYTES 
monocytes bound  fewer  Fn-ms  at  4°C  than  at  37°C;  both  achieved  maximal 
binding at similar  Fn-ms/cell ratios; and phenylmethylsulfonyl fluoride did not 
inhibit Fn-ms binding to either cell type. Most dramatically, monoclonal anti-Fn 
antibodies that inhibited binding of Fn-ms to one cell type inhibited binding to 
both;  conversely,  monoclonal  anti-Fn  antibodies  that  did  not  inhibit  Fn-ms 
binding to either cell type did not inhibit binding to the other. 
Fn will stimulate  PMN  to a  more actively phagocytic state,  like that induced 
in monocytes, if the PMN are first exposed to C5a or N-formyl-methionyl-leucyl- 
phenylalanine. This effect occurs without apparent change in the number of Fn 
receptors. We conclude that the PMN and monocyte receptors for Fn are very 
similar,  but that their milieu is  very different in the  two cells as purified from 
peripheral  blood.  Whereas  Fn  induces  increased  phagocytosis  in  monocytes, 
PMN must be activated before the Fn can be effective. 
We thank Karen Leighty for excellent editorial assistance. 
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